Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement (FHHN) is a form of familial primary hypomagnesemia (FPH), characterized by recurrent urinary...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Astellas Pharma Global Development, Inc.
Other
Atsena Therapeutics, Inc.
Other
BioRamo, LLC
Other
Fresenius Medical Care North America
Other
Pharmedic Company
Other
R & D Laboratories, Inc.
Other
Roxane Laboratories, Inc.
Other
Takeda Pharmaceuticals U.S.A., Inc.
Other
University of Texas Health Science Center at Dallas
Other